Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C29H32O6 |
Molecular Weight | 476.5608 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@]1(C)CC[C@]3([H])C4=C(CC[C@@]23[H])C=C(OC(=O)C5=CC=CC=C5)C=C4
InChI
InChIKey=VQHGRIUWSVCJPX-HSZAMCLRSA-N
InChI=1S/C29H32O6/c1-17(30)33-26-16-25-24-11-9-20-15-21(35-28(32)19-7-5-4-6-8-19)10-12-22(20)23(24)13-14-29(25,3)27(26)34-18(2)31/h4-8,10,12,15,23-27H,9,11,13-14,16H2,1-3H3/t23-,24-,25+,26-,27+,29+/m1/s1
Molecular Formula | C29H32O6 |
Molecular Weight | 476.5608 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.drugs.com/international/holin.htmlCurator's Comment: Description was created based on several sources, including
http://www.genome.jp/dbget-bin/www_bget?dr:D01989
Sources: https://www.drugs.com/international/holin.html
Curator's Comment: Description was created based on several sources, including
http://www.genome.jp/dbget-bin/www_bget?dr:D01989
Estriol acetate benzoate is a semisynthetic, steroidal estrogen. Estriol benzoate diacetate is reported as an ingredient of Holin in Japan. It is an estrogen receptor agonist.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2093866 Sources: http://www.genome.jp/dbget-bin/www_bget?dr:D01989 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: http://www.ndrugs.com/?s=holin |
Primary | Holin Approved UseMenopausal hormone replacement therapy |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ndrugs.com/?s=holin
Curator's Comment: Oral or vaginal
Oral Menopausal HRT
Adult: 0.5-3 mg daily for 1 mth followed by 0.5-1 mg daily; or 0.25-2 mg daily in combination with other natural oestrogens. A progestogen is required if administered to women with a uterus.
Oral Infertility due to cervical hostility
Adult: 0.25-1 mg/day on days 6-15 of the menstrual cycle. Increase dose each mth until an optimal effect is obtained.
Oral Atrophy of the lower urogenital tract related to estrogen deficiency
Adult: 4-8 mg/day for the 1 st wk then taper down to 1-2 mg/day. Vaginal Menopausal atrophic vaginitis
Adult: As 0.01% or 0.1% cream or 500 mcg pessary: Apply 500 mcg once daily, reduce to twice wkly subsequently.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 06:19:13 GMT 2023
by
admin
on
Sat Dec 16 06:19:13 GMT 2023
|
Record UNII |
64EY62BBUA
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Estriol acetate benzoate
Created by
admin on Sat Dec 16 06:19:13 GMT 2023 , Edited by admin on Sat Dec 16 06:19:13 GMT 2023
|
PRIMARY | |||
|
656637
Created by
admin on Sat Dec 16 06:19:13 GMT 2023 , Edited by admin on Sat Dec 16 06:19:13 GMT 2023
|
PRIMARY | |||
|
SUB77781
Created by
admin on Sat Dec 16 06:19:13 GMT 2023 , Edited by admin on Sat Dec 16 06:19:13 GMT 2023
|
PRIMARY | |||
|
2508-47-6
Created by
admin on Sat Dec 16 06:19:13 GMT 2023 , Edited by admin on Sat Dec 16 06:19:13 GMT 2023
|
PRIMARY | |||
|
64EY62BBUA
Created by
admin on Sat Dec 16 06:19:13 GMT 2023 , Edited by admin on Sat Dec 16 06:19:13 GMT 2023
|
PRIMARY | |||
|
CHEMBL193482
Created by
admin on Sat Dec 16 06:19:13 GMT 2023 , Edited by admin on Sat Dec 16 06:19:13 GMT 2023
|
PRIMARY | |||
|
DTXSID8057697
Created by
admin on Sat Dec 16 06:19:13 GMT 2023 , Edited by admin on Sat Dec 16 06:19:13 GMT 2023
|
PRIMARY | |||
|
100000138324
Created by
admin on Sat Dec 16 06:19:13 GMT 2023 , Edited by admin on Sat Dec 16 06:19:13 GMT 2023
|
PRIMARY |